threshold

5 papers and 8 presentations; 13 titles.

Back to keywords

Conference ×	Year ×	Title ×	Authors	Extras	Pages
PHUSE US	2026	Anonymisation Strategies for Policy 0070 and PRCI Submissions [presentation]	Stuart Donald	source	16
PHUSE US	2026	Anonymization Insights from 2025 [presentation]	Honz Slipka	source	11
PHUSE US	2026	From Complexity to Consistency: Scalable Anonymization Across Clinical Trial Portfolios [presentation]	Ahmed Eldafrawy, Danielle DiBonaventura	source	22
PHUSE EU	2021	Navigating the Evolving Regulations for Health Canada [presentation]	Gina Bennet	source video	20
PHUSE US	2021	A Quantitative and Metrics-driven Framework for Maximizing Data Utility While Balancing Re-identification Risk [presentation]	Stephen Doogan	source video	18
PHUSE US	2021	Software Demonstration: SD11: Streamline Your Quantitative Anonymization Process and Deliver Consistent Outputs for Every Disclosure Scenario [presentation]	Stephen Doogan	source	8
PHUSE EU	2020	Achieving Balance - Approaching Anonymisation with Quantified Risk [presentation]	Cathal Gallagher	source video	27
PHUSE US	2020	A Case Study: Data Transparency of Clinical Trial Data	Sherry Meeh	source presentation source	8
PHUSE EU	2019	Integrated Data and Document Anonymisation for Efficient Data Sharing [presentation]	Ali Dootson, Cathal Gallagher	source	27
PHUSE EU	2017	Assessing New CFDA Requirements on Data Integrity Using Risk-Based Monitoring and Enrollment Patterns	Wenjun Bao, Richard C. Zink, Geoffrey A. Mann	source presentation source	13
PHUSE EU	2016	A Standardised Approach to De-identification	Christopher C. Hurley	source presentation source	13
PharmaSUG	2014	Risk-Based Monitoring of Clinical Trials Using JMP Clinical	Richard C. Zink, Kelci J. Miclaus	source	15
SGF	2014	Risk-Based Monitoring of Clinical Trials Using JMP Clinical	Richard C. Zink	source	14

Back to keywords